Study Summary
This trial is investigating whether a new pain medication can help people with tennis elbow.
- Tennis Elbow
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 3 weeks to 6 months
Trial Safety
Phase-Based Safety
Trial Design
2 Treatment Groups
Blood Flow Restricted Physical Therapy
1 of 2
Physical Therapy
1 of 2
Active Control
Non-Treatment Group
250 Total Participants · 2 Treatment Groups
Primary Treatment: Blood Flow Restricted Physical Therapy · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 65 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are individuals over fifty being enrolled in this trial?
"This experiment requires participants to be of legal age and not exceed 65 years old." - Anonymous Online Contributor
Could I become a participant in this research initiative?
"This medical study is hoping to recruit 250 participants who have been diagnosed with lateral epicondylitis by an orthopaedic specialist and can confirm the diagnosis via ultrasound. Prospective volunteers must be aged 18-65, literate in English, and capable of providing written consent." - Anonymous Online Contributor
Are there opportunities to participate in this experiment at the current time?
"Affirmative. According to clinicaltrials.gov, this medical trial is in the recruitment process and has been since May 20th 2022 when it was initially posted. It has been updated most recently on November 1st 2022 with a goal of enrolling 250 patients from one site." - Anonymous Online Contributor
How many participants are engaged in this clinical research?
"Affirmative. According to clinicaltrials.gov, this medical study is recruiting participants at present - it was first advertised on May 20th 2022 and most recently modified on November 1st 2022. Presently, the trial requires 250 volunteers from one site." - Anonymous Online Contributor